Literature DB >> 30092689

Reminiscence therapy for dementia: an abridged Cochrane systematic review of the evidence from randomized controlled trials.

Laura O' Philbin1, Bob Woods1, Emma M Farrell1, Aimee E Spector2, Martin Orrell3.   

Abstract

INTRODUCTION: Reminiscence therapy (RT) is a popular psychosocial intervention widely used in dementia care. It involves discussion of past events and experiences, using tangible prompts to evoke memories or stimulate conversation. Areas covered: The aim of this review is to evaluate the effectiveness of RT for people with dementia. It includes studies from the specialized register of the Cochrane Dementia and Cognitive Improvement Group (ALOIS). Searches yielded 185 records of which 22 (n = 1972) were eligible for inclusion. The meta-analysis comprised of data from 16 studies (n = 1749 participants). The review included four large multicenter high-quality studies and several smaller studies of reasonable quality. Outcomes of interest were quality of life, communication, depression, and cognition at posttreatment and later follow-up. Expert commentary: RT has the potential to improve psychosocial outcomes for people with dementia. Effects are small and can be inconsistent, varying across intervention modality and setting. Individual approaches were associated with improved cognition and mood. Group approaches were linked to improved communication. The impact on quality of life appeared most promising in care home settings. Diversity in reminiscence approaches makes it difficult to compare them, and the field would benefit from the development, evaluation, use, and sharing of standardized approaches.

Entities:  

Keywords:  Alzheimer’s; Reminiscence therapy; dementia; life review; non-pharmacological; psychosocial

Mesh:

Year:  2018        PMID: 30092689     DOI: 10.1080/14737175.2018.1509709

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  5 in total

1.  A mixed-methods pilot study of 'LIFEView' audiovisual technology: Virtual travel to support well-being and quality of life in palliative and end-of-life care patients.

Authors:  Monisha Kabir; Jill L Rice; Shirley H Bush; Peter G Lawlor; Colleen Webber; Pamela A Grassau; Bahareh Ghaedi; Misha Dhuper; Rebekah Hackbusch
Journal:  Palliat Med       Date:  2020-05-08       Impact factor: 4.762

2.  Older Women's Loneliness and Depression Decreased by a Reminiscence Program in Times of COVID-19.

Authors:  Sacramento Pinazo-Hernandis; Alicia Sales; Dolores Martinez
Journal:  Front Psychol       Date:  2022-02-21

Review 3.  Effects of Reminiscence Therapy on Cognition, Depression and Quality of Life in Elderly People with Alzheimer's Disease: A Systematic Review of Randomized Controlled Trials.

Authors:  Davide Maria Cammisuli; Gabriele Cipriani; Emanuele Maria Giusti; Gianluca Castelnuovo
Journal:  J Clin Med       Date:  2022-09-28       Impact factor: 4.964

4.  Toward a theory-based specification of non-pharmacological treatments in aging and dementia: Focused reviews and methodological recommendations.

Authors:  Sietske A M Sikkes; Yi Tang; Roos J Jutten; Linda M P Wesselman; Lyn S Turkstra; Henry Brodaty; Linda Clare; Erin Cassidy-Eagle; Kay L Cox; Gaël Chételat; Sophie Dautricourt; Klodian Dhana; Hiroko Dodge; Rose-Marie Dröes; Benjamin M Hampstead; Thomas Holland; Amit Lampit; Kate Laver; Antoine Lutz; Nicola T Lautenschlager; Susan M McCurry; Franka J M Meiland; Martha Clare Morris; Kimberly D Mueller; Ruth Peters; Gemma Ridel; Aimee Spector; Jenny T van der Steen; Jeanette Tamplin; Zara Thompson; Alex Bahar-Fuchs
Journal:  Alzheimers Dement       Date:  2020-11-20       Impact factor: 21.566

5.  The use of digital technologies by people with mild-to-moderate dementia during the COVID-19 pandemic: A positive technology perspective.

Authors:  Catherine V Talbot; Pam Briggs
Journal:  Dementia (London)       Date:  2022-03-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.